Literature DB >> 8609276

Guidelines of care for sclerotherapy treatment of varicose and telangiectatic leg veins. American Academy of Dermatology.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8609276     DOI： 10.1016/s0190-9622(96)90467-3

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  5 in total

Review 1.  [Sclerotherapy for varicosities].

Authors:  F Pannier; E Rabe
Journal:  Hautarzt       Date:  2006-01       Impact factor: 0.751

Review 2.  S2k guidelines: diagnosis and treatment of varicose veins.

Authors:  F Pannier; T Noppeney; J Alm; F X Breu; G Bruning; I Flessenkämper; H Gerlach; K Hartmann; B Kahle; H Kluess; E Mendoza; D Mühlberger; A Mumme; H Nüllen; K Rass; S Reich-Schupke; D Stenger; M Stücker; C G Schmedt; T Schwarz; J Tesmann; J Teßarek; S Werth; E Valesky
Journal:  Hautarzt       Date:  2022-04-19       Impact factor: 1.198

3.  Sclerotherapy for Reticular Veins in the Lower Limbs: A Triple-Blind Randomized Clinical Trial.

Authors:  Matheus Bertanha; Rodrigo Gibin Jaldin; Regina Moura; Rafael Elias Farres Pimenta; Jamil Victor de Oliveira Mariúba; Carlos Eduardo Pinheiro Lúcio Filho; Giovana Piteri Alcantara; Carlos Roberto Padovani; Winston Bonetti Yoshida; Marcone Lima Sobreira
Journal:  JAMA Dermatol       Date:  2017-12-01       Impact factor: 10.282

4.  Polidocanol versus hypertonic glucose for sclerotherapy treatment of reticular veins of the lower limbs: study protocol for a randomized controlled trial.

Authors:  Matheus Bertanha; Marcone Lima Sobreira; Carlos Eduardo Pinheiro Lúcio Filho; Jamil Victor de Oliveira Mariúba; Rafael Elias Farres Pimenta; Rodrigo Gibin Jaldin; Andrei Moroz; Regina Moura; Hamilton Almeida Rollo; Winston Bonetti Yoshida
Journal:  Trials       Date:  2014-12-19       Impact factor: 2.279

5.  Polidocanol versus glucose in the treatment of telangiectasia of the lower limbs (PG3T): Protocol for a randomized, controlled clinical trial.

Authors:  Matheus Bertanha; Paula Angeleli Bueno de Camargo; Regina Moura; Winston Bonetti Yoshida; Rafael Elias Farres Pimenta; Jamil Victor de Oliveira Mariúba; Giovana Piteri Alcantara; Dênia Reis de Paula; Marcone Lima Sobreira
Journal:  Medicine (Baltimore)       Date:  2016-09       Impact factor: 1.889
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.